In our meta-analysis, we systematically enrolled all available up-to-date studies related with GSTP1 IIe105Val, GSTM1 and GSTT1 null genetic polymorphisms and the efficacy of platinum-based chemotherapy to NSCLC patients. Here, GSTP1 is linked to non-small cell lung carcinoma.